DE3500184A1 - Mikroorganismus und plasmid fuer konstitutive creatinamidinohydrolase-bildung sowie verfahren zur herstellung derselben - Google Patents
Mikroorganismus und plasmid fuer konstitutive creatinamidinohydrolase-bildung sowie verfahren zur herstellung derselbenInfo
- Publication number
- DE3500184A1 DE3500184A1 DE19853500184 DE3500184A DE3500184A1 DE 3500184 A1 DE3500184 A1 DE 3500184A1 DE 19853500184 DE19853500184 DE 19853500184 DE 3500184 A DE3500184 A DE 3500184A DE 3500184 A1 DE3500184 A1 DE 3500184A1
- Authority
- DE
- Germany
- Prior art keywords
- plasmid
- coli
- pbt
- fragment
- pvu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 25
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 7
- 239000013612 plasmid Substances 0.000 title claims description 67
- 230000015572 biosynthetic process Effects 0.000 title description 13
- 241000588724 Escherichia coli Species 0.000 claims abstract description 52
- 241000589776 Pseudomonas putida Species 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 24
- 239000012634 fragment Substances 0.000 claims description 37
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims description 24
- 230000000694 effects Effects 0.000 claims description 18
- 229960003624 creatine Drugs 0.000 claims description 14
- 239000006046 creatine Substances 0.000 claims description 14
- 239000013598 vector Substances 0.000 claims description 13
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 claims description 10
- 229920000936 Agarose Polymers 0.000 claims description 7
- 238000003776 cleavage reaction Methods 0.000 claims description 7
- 230000007017 scission Effects 0.000 claims description 7
- 102000003992 Peroxidases Human genes 0.000 claims description 6
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 6
- 229960000723 ampicillin Drugs 0.000 claims description 6
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 6
- 108091008146 restriction endonucleases Proteins 0.000 claims description 6
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 claims description 4
- 108010060059 Sarcosine Oxidase Proteins 0.000 claims description 4
- 102000008118 Sarcosine oxidase Human genes 0.000 claims description 4
- SVDAGORERCSAIV-UHFFFAOYSA-N 2-(n-ethyl-3-methylanilino)ethanesulfonic acid Chemical class OS(=O)(=O)CCN(CC)C1=CC=CC(C)=C1 SVDAGORERCSAIV-UHFFFAOYSA-N 0.000 claims description 3
- 230000003321 amplification Effects 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 238000004040 coloring Methods 0.000 claims 1
- 230000008569 process Effects 0.000 abstract description 5
- 108020004414 DNA Proteins 0.000 description 40
- 102000053602 DNA Human genes 0.000 description 38
- 102000004157 Hydrolases Human genes 0.000 description 27
- 108090000604 Hydrolases Proteins 0.000 description 27
- 108090000623 proteins and genes Proteins 0.000 description 27
- 102000004190 Enzymes Human genes 0.000 description 21
- 108090000790 Enzymes Proteins 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 18
- 230000014509 gene expression Effects 0.000 description 17
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108010077078 Creatinase Proteins 0.000 description 10
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 241000589516 Pseudomonas Species 0.000 description 5
- 238000004806 packaging method and process Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241001646716 Escherichia coli K-12 Species 0.000 description 4
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 210000003705 ribosome Anatomy 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 108010077895 Sarcosine Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229940043230 sarcosine Drugs 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 2
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 238000012270 DNA recombination Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 239000002676 xenobiotic agent Substances 0.000 description 2
- 101000870242 Bacillus phage Nf Tail knob protein gp9 Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 101000894568 Catharanthus roseus Catharanthine synthase Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 230000003682 DNA packaging effect Effects 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000901842 Escherichia coli W Species 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 101710171264 Peroxidase 20 Proteins 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- -1 ammonium ions Chemical class 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 101150045500 galK gene Proteins 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000027086 plasmid maintenance Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000007363 regulatory process Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/848—Escherichia
- Y10S435/849—Escherichia coli
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/874—Pseudomonas
- Y10S435/877—Pseudomonas putida
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19853500184 DE3500184A1 (de) | 1985-01-04 | 1985-01-04 | Mikroorganismus und plasmid fuer konstitutive creatinamidinohydrolase-bildung sowie verfahren zur herstellung derselben |
AU51631/85A AU561319B2 (en) | 1985-01-04 | 1985-12-24 | Plasmid and microorganism for constitutive creatinaminohydrolase formation |
JP60292383A JPH062050B2 (ja) | 1985-01-04 | 1985-12-26 | 構成性クレアチンアミジノヒドロラーゼを形成する微生物及びその製法 |
YU204985A YU204985A (sh) | 1985-01-04 | 1985-12-27 | Mikroorganizem in plazmid za konstitutivno tvorbo kreatinamidino-hidrolaze kot tudi postopek za njegovo pripravo |
GR853154A GR853154B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1985-01-04 | 1985-12-30 | |
CA000498900A CA1309960C (en) | 1985-01-04 | 1986-01-02 | Micro-organisms and plasmids for the constitutive formation of creatinamidinohydrolase and processes for the production thereof |
ZA8630A ZA8630B (en) | 1985-01-04 | 1986-01-03 | Micro-organism and plasmid for constitutive creatinamidinohydrolase formation,as well as process for the production thereof |
CS8675A CZ279427B6 (cs) | 1985-01-04 | 1986-01-03 | Způsob pěstování mikroorganismu |
EP86100066A EP0187138B1 (de) | 1985-01-04 | 1986-01-03 | Mikroorganismus und Plasmid für konstitutive Creatinamidino-hydrolase-Bildung sowie Verfahren zur Herstellung derselben |
ES550669A ES8704543A1 (es) | 1985-01-04 | 1986-01-03 | Procedimiento para preparar un microorganismo |
SK75-86A SK278079B6 (en) | 1985-01-04 | 1986-01-03 | Microorganism of race escherichia coli or pseudomonas putida, method of its growing and recombinant dna |
IE1686A IE58794B1 (en) | 1985-01-04 | 1986-01-03 | Micro-organisms and plasmids for the constitutive formation of creatinamidinohydrolase and process for the production thereof |
UA4002500A UA6152A1 (uk) | 1985-01-04 | 1986-01-03 | СПОСІБ ОДЕРЖАННЯ ШТАММІВ БАКТЕРІЙ - ESCHERICHIA COLI i PSEUDOMONAS PURIDA - ПРОДУЦЕНТІВ КРЕАТІНАМІДІНОГІДРОЛАЗИ |
DE8686100066T DE3684787D1 (de) | 1985-01-04 | 1986-01-03 | Mikroorganismus und plasmid fuer konstitutive creatinamidino-hydrolase-bildung sowie verfahren zur herstellung derselben. |
DK3086A DK3086A (da) | 1985-01-04 | 1986-01-03 | Mikroorganisme og plasmid til konstitutiv creatinamidinohydrolasedannelse samt fremgangsmaade til deres fremstilling |
SU864002500A SU1523055A3 (ru) | 1985-01-04 | 1986-01-03 | Способ получени штаммов бактерий ЕSснеRIснIа coLI и РSеUDомоNаS рUтIDа-продуцентов креатинамидиногидролазы |
AT86100066T ATE74964T1 (de) | 1985-01-04 | 1986-01-03 | Mikroorganismus und plasmid fuer konstitutive creatinamidino-hydrolase-bildung sowie verfahren zur herstellung derselben. |
US06/816,565 US4861717A (en) | 1985-01-04 | 1986-01-06 | Microorganisms and plasmids for the constitutive formation of creatinamidinohydrolase and processes for the production thereof |
LV930466A LV5533A3 (lv) | 1985-01-04 | 1993-06-02 | Panemiens escherichia coli un pseudomonas putida celmu - kreatina amidinhidrolazes producentu iegusanai |
JP5189871A JPH07102140B2 (ja) | 1985-01-04 | 1993-07-30 | 組換えdna |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19853500184 DE3500184A1 (de) | 1985-01-04 | 1985-01-04 | Mikroorganismus und plasmid fuer konstitutive creatinamidinohydrolase-bildung sowie verfahren zur herstellung derselben |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3500184A1 true DE3500184A1 (de) | 1986-08-14 |
Family
ID=6259284
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19853500184 Withdrawn DE3500184A1 (de) | 1985-01-04 | 1985-01-04 | Mikroorganismus und plasmid fuer konstitutive creatinamidinohydrolase-bildung sowie verfahren zur herstellung derselben |
DE8686100066T Expired - Lifetime DE3684787D1 (de) | 1985-01-04 | 1986-01-03 | Mikroorganismus und plasmid fuer konstitutive creatinamidino-hydrolase-bildung sowie verfahren zur herstellung derselben. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8686100066T Expired - Lifetime DE3684787D1 (de) | 1985-01-04 | 1986-01-03 | Mikroorganismus und plasmid fuer konstitutive creatinamidino-hydrolase-bildung sowie verfahren zur herstellung derselben. |
Country Status (17)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4990453A (en) * | 1987-05-12 | 1991-02-05 | Boehringer Mannheim Gmbh | Modified pseudomonas putida creatine amidinohydrolase |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3500184A1 (de) * | 1985-01-04 | 1986-08-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Mikroorganismus und plasmid fuer konstitutive creatinamidinohydrolase-bildung sowie verfahren zur herstellung derselben |
JPS62208281A (ja) * | 1986-03-07 | 1987-09-12 | Kikkoman Corp | クレアチナ−ゼの製造法 |
JPS62205786A (ja) * | 1986-03-07 | 1987-09-10 | Kikkoman Corp | 新規な組み換え体dna |
JPS6437292A (en) * | 1987-08-04 | 1989-02-07 | Toyo Jozo Kk | Dna having genetic information of creatinase and use thereof |
JP2527035B2 (ja) * | 1989-06-16 | 1996-08-21 | 東洋紡績株式会社 | クレアチニン・アミドヒドロラ―ゼをコ―ドする遺伝子を含有するdna断片、該dna断片を有する組換えベクタ―及び該組換えベクタ―を有する形質転換体、並びにクレアチニン・アミドヒドロラ―ゼの製造方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4039384A (en) * | 1975-04-05 | 1977-08-02 | Noda Institute For Scientific Research | Creatinine amidohydrolase and creatine amidinohydrolase and process for producing them |
JPS51118884A (en) * | 1975-04-05 | 1976-10-19 | Noda Sangyo Kagaku Kenkyusho | Process for preparing creatine amidinohydrolase |
DE3500184A1 (de) * | 1985-01-04 | 1986-08-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Mikroorganismus und plasmid fuer konstitutive creatinamidinohydrolase-bildung sowie verfahren zur herstellung derselben |
-
1985
- 1985-01-04 DE DE19853500184 patent/DE3500184A1/de not_active Withdrawn
- 1985-12-24 AU AU51631/85A patent/AU561319B2/en not_active Ceased
- 1985-12-26 JP JP60292383A patent/JPH062050B2/ja not_active Expired - Lifetime
- 1985-12-27 YU YU204985A patent/YU204985A/sh unknown
- 1985-12-30 GR GR853154A patent/GR853154B/el unknown
-
1986
- 1986-01-02 CA CA000498900A patent/CA1309960C/en not_active Expired - Lifetime
- 1986-01-03 CZ CS8675A patent/CZ279427B6/cs unknown
- 1986-01-03 UA UA4002500A patent/UA6152A1/uk unknown
- 1986-01-03 IE IE1686A patent/IE58794B1/en not_active IP Right Cessation
- 1986-01-03 EP EP86100066A patent/EP0187138B1/de not_active Expired - Lifetime
- 1986-01-03 ZA ZA8630A patent/ZA8630B/xx unknown
- 1986-01-03 AT AT86100066T patent/ATE74964T1/de not_active IP Right Cessation
- 1986-01-03 SU SU864002500A patent/SU1523055A3/ru active
- 1986-01-03 SK SK75-86A patent/SK278079B6/sk unknown
- 1986-01-03 DK DK3086A patent/DK3086A/da not_active Application Discontinuation
- 1986-01-03 DE DE8686100066T patent/DE3684787D1/de not_active Expired - Lifetime
- 1986-01-03 ES ES550669A patent/ES8704543A1/es not_active Expired
- 1986-01-06 US US06/816,565 patent/US4861717A/en not_active Expired - Fee Related
-
1993
- 1993-07-30 JP JP5189871A patent/JPH07102140B2/ja not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4990453A (en) * | 1987-05-12 | 1991-02-05 | Boehringer Mannheim Gmbh | Modified pseudomonas putida creatine amidinohydrolase |
Also Published As
Publication number | Publication date |
---|---|
DE3684787D1 (de) | 1992-05-21 |
EP0187138A2 (de) | 1986-07-09 |
ES550669A0 (es) | 1987-04-16 |
ZA8630B (en) | 1986-09-24 |
AU5163185A (en) | 1986-07-10 |
AU561319B2 (en) | 1987-05-07 |
ES8704543A1 (es) | 1987-04-16 |
IE58794B1 (en) | 1993-11-17 |
JPH062050B2 (ja) | 1994-01-12 |
JPS61162170A (ja) | 1986-07-22 |
US4861717A (en) | 1989-08-29 |
JPH06233687A (ja) | 1994-08-23 |
GR853154B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1986-04-24 |
EP0187138B1 (de) | 1992-04-15 |
SK7586A3 (en) | 1995-12-06 |
SK278079B6 (en) | 1995-12-06 |
CA1309960C (en) | 1992-11-10 |
ATE74964T1 (de) | 1992-05-15 |
SU1523055A3 (ru) | 1989-11-15 |
IE860016L (en) | 1986-07-04 |
JPH07102140B2 (ja) | 1995-11-08 |
DK3086A (da) | 1986-07-05 |
YU204985A (sh) | 1992-09-07 |
CZ7586A3 (en) | 1994-11-16 |
EP0187138A3 (en) | 1988-03-23 |
DK3086D0 (da) | 1986-01-03 |
CZ279427B6 (cs) | 1995-04-12 |
UA6152A1 (uk) | 1994-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0334841B1 (de) | Microorganismen and plasmide für die 2,4-dichlorphenoxyessigsäure (2,4-d)-monooxigenase - bildung und verfahren zur herstellung dieser plasmide und stämme | |
DE69721282T2 (de) | In vitro transpositionsystem unter verwendung einer modifizierten tn5 transposase | |
EP0069697A2 (de) | Herstellung und Anwendung von Plasmiden mit Genen für die Biosynthese von L-Prolin | |
DE4018441A1 (de) | Rekombinantes restriktionsenzym sau3ai | |
DE69113390T2 (de) | Verfahren zur Klonierung und Herstellung von Restriktionsendonuklease Nco I. | |
DE3423899C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
EP0187138B1 (de) | Mikroorganismus und Plasmid für konstitutive Creatinamidino-hydrolase-Bildung sowie Verfahren zur Herstellung derselben | |
DE69627787T2 (de) | Actinomyceten-Promotor | |
CH640268A5 (en) | Process for the preparation of filamentous hybrid phages, novel hybrid phages and their use | |
DE69329164T2 (de) | Protein mit Alpha-Glukosidase-Aktivität, DNS mit dessen genetischer Information und Herstellung von Alpha-Glukosidase | |
DE3735379A1 (de) | Rna-polymerase-gen, verfahren zu seiner herstellung und mikroorganismus mit diesem gen | |
DE3850456T2 (de) | Klonierung des isoamylaseenzym kodierenden Gens und seine Verwendung zur Herstellung dieses Enzyms. | |
DE69121752T2 (de) | Kloniertes Tyrosin-Phenol-Lyasegen, ein rekombinantes Plasmid, das dieses enthält und mit diesem Plasmid transformierte E. Coli | |
DD251790A5 (de) | Verfahren zur Herstellung von Creatinamidinohydrolase | |
EP0524604B1 (de) | Gentechnologisches Verfahren zur Herstellung von S-(+)-2,2-Dimethylcyclopropancarboxamid mittels Mikroorganismen | |
DE3640382C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
DE3530935C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
DE2930922C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
DE3420298C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
DE69633993T2 (de) | Zirkuläre Plasmide aus Rhodococcus | |
DE3512435A1 (de) | Restriktionsendonuklease asp 718, ihre gewinnung und verwendung | |
EP0158872A1 (de) | Das Streptomyceten-Plasmid pSG5, Verfahren zu seiner Gewinnung und seine Verwendung | |
DE3008645A1 (de) | Plasmid puc2 und verfahren zum isolieren von plasmid puc2 aus streptomyces fradiae | |
DE3011995A1 (de) | Plasmid puc7 und verfahren zum isolieren von plasmid puc7 aus streptomyces espinosus subsp. acanthus | |
EP0307730A2 (de) | Expression von Mutarotase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8141 | Disposal/no request for examination |